We have finally been approved by the Institute of Regenerative and Cellular Medicine (IRCM) to do a study that is three years in the making.
One of the most significant causes of low back pain in the world is related to lumbar facet joints.
We are going to perform a safety study with Extracellular Vesicles in patients with pain generated from lumbar facet joints.
In short, we are planning to contrast these results with the current standard of care procedure. Would the standard change if Extracellular Vesicles prove to be a superior option to current treatments such as Radiofrequency Neurotomies, which typically are effective for about 6 months?
James E. Wilson M.D.